Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

At the 2025 edition of the International Society of Pharmaceutical Engineering (ISPE) Europe Annual Conference, held in ...

Last year, Pirelli showed off its first 5G-connected Cyber Tyre. This year, it's taking that connectivity a step further.

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American manufacturing.